SpaceX Investors Could Be in for a Rude Awakening, According to 1 Top Wall Street Analyst

Morningstar valued SpaceX at $63 per share, about 70% below the stock's June 16, 2026 midday price and well under even bullish estimates. The report flags near-term dilution as private holders and employees gain liquidity, plus governance risk from Elon Musk's 82% voting control and potential large acquisitions. Morningstar's optimistic case is $154 per share, while Oppenheimer's $190 target still sits below the stock's recent trading level.

Analysis

The key market issue is not whether the business is excellent, but whether the post-IPO ownership structure can absorb inevitable selling pressure. A tiny float plus index-driven demand can support a vertical move for days or weeks, but once employee/early backer liquidity opens, price discovery becomes much less forgiving because there is no natural earnings yield to anchor the tape. In that setup, even a modest change in marginal demand can create a disproportionate air pocket.

The competitive angle is more interesting than the headline valuation call. Starlink’s multiple is implicitly pricing a near-monopoly on high-value satellite connectivity, but any credible cost/performance alternative from a cash-rich platform like Amazon changes the terminal assumptions, not just the near-term growth rate. If Amazon is willing to subsidize Leo to win enterprise and government contracts, SpaceX’s best business may be forced into lower-margin pricing exactly when investors are paying peak multiple for future optionality.

Governance is the real second-order risk because it converts a growth story into a control premium problem. With concentrated voting power, the market cannot rely on ordinary minority-shareholder protections, which means acquisition risk, related-party style strategic moves, and dilution are not tail events but structurally embedded. That is especially dangerous in a name trading above even optimistic sell-side targets, because the stock has no cushion if management chooses empire-building over per-share compounding.

The contrarian take is that the first drawdown may be sharper than the eventual fundamental re-rating. This kind of asset can stay inflated longer than skeptics expect, but once the lockup/supply overhang and index-chasing bid are fully digested, the stock could gap down 20-30% quickly before any long-horizon deterioration in fundamentals is even visible. The right framing is not “is it a good company?” but “what is the cheapest catalyst that breaks the consensus narrative?” — and here that catalyst is supply, not operations.

Key Decisions for Investors

• Avoid initiating fresh longs in SpaceX at current levels; wait for post-IPO supply absorption and a 15-20% retracement before considering entry, because upside is mechanically capped while downside is accelerated by float expansion.
• Express a relative-value short via short SpaceX / long AMZN on a 1-3 month horizon if Leo commercialization gains traction; the pair captures a re-rating in the challenger while fading multiple compression in the incumbent.
• For tactical downside exposure, buy put spreads on SpaceX once insider liquidity dates are within 30 days; target a 2-3x payoff on a 20% selloff, with premium defined if the stock remains momentum-driven.
• Reduce or hedge TSLA exposure if you believe a SpaceX-Tesla strategic transaction risk is rising; the market will penalize TSLA first on any credible hint of cross-platform capital allocation, even before formal deal terms.
• Underweight MORN after a successful thesis call; if the stock stays strong, the market may begin pricing its analytical credibility premium, but if SpaceX sells off, the call is already monetized and the risk/reward skews to event fade.